Free Market Concept Not Applicable In Pharma Sector, Says India NPPA Chairman A.K. Banerjee: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
While the need for price control of drugs continues to be a hot topic for debate, Dr A.K. Banerjee, the man carrying the onus of regulating drug prices in India as the chairman of the National Pharmaceuticals Pricing Authority, presents his viewpoint to PharmAsia News' India bureau on the need for price control in the country.
You may also be interested in...
Indian Parliamentary Committee Lashes Out At Pricing Watchdog NPPA
The committee is concerned about the huge gap between claims raised by the National Pharmaceuticals Pricing Authority for overcharging and the actual amounts recovered, so far less than 10 percent of the total.
Indian Parliamentary Committee Lashes Out At Pricing Watchdog NPPA
The committee is concerned about the huge gap between claims raised by the National Pharmaceuticals Pricing Authority for overcharging and the actual amounts recovered, so far less than 10 percent of the total.
Indian Parliamentary Committee Lashes Out At Pricing Watchdog NPPA
NEW DELHI - Concerned by the slugglish performance of the pricing of medicines - in recovering funds from defaulting drug makers, the Parliamentary Standing Committee on chemicals and fertilizers has asked the National Pharmaceuticals Pricing Authority to bring the process up to speed